NAMENDA XR should not be taken by anyone who is allergic (hypersensitive) to memantine, the active substance in NAMENDA XR, or who has had a bad reaction to NAMENDA XR or any of its ingredients.
Before starting NAMENDA XR, talk to the healthcare provider about all of the patient's past and present medical conditions, including:
If the patient is taking other medications (including those without a prescription), ask the healthcare provider if NAMENDA XR is right for the patient.
The most common side effects associated with NAMENDA XR treatment are headache, diarrhea, and dizziness. This is not a complete list of side effects.
NAMENDA XR extended-release capsules are approved for the treatment of moderate to severe Alzheimer's disease. NAMENDA XR is available by prescription only.
You are encouraged to report negative side effects of prescription drugs to the FDA.
medwatch or call 1-800-FDA-1088.
NAMENDA XR ® and their designs are registered trademarks of Merz Pharma GmbH & Co. KGaA. Actavis™ and its design are trademarks of Actavis, Inc. or its affiliates.
© 2015 Actavis. All rights reserved. NXR27809 03/15